A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants With Alpha (α)-Thalassemia
Status:
Recruiting
Trial end date:
2026-06-18
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the efficacy and safety of luspatercept plus best
supportive care (BSC) vs placebo plus BSC on anemia in participants with α-thalassemia
hemoglobin H (HbH) disease.